<DOC>
	<DOCNO>NCT00314249</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy safety milnacipran dosage 100 mg/day treatment fibromyalgia syndrome pain associate fibromyalgia .</brief_summary>
	<brief_title>Study Milnacipran Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>diagnosis fibromyalgia define 1990 American College Rheumatology ( ACR ) Criteria psychiatric illness , depression , suicidal risk , substance abuse , pulmonary dysfunction , renal impairment , active cardiac disease , liver disease , autoimmune disease , cancer , inflammatory bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Fibromyalgia</keyword>
</DOC>